Hey Atlanta - this is your last chance to register for Monday's MedTech Innovation event at Portal! We have a fantastic panel lined up featuring Terri Kim (Lunit Cancer Screening), Omer Inan (Cardiosense), Samirkumar Patel (Moonlight Therapeutics), and Mason A. Chilmonczyk, PhD (Andson Biotech). Interested in attending? Register below! https://lnkd.in/gwtRPZcb
Andson Biotech
生物技术研究
Atlanta，Georgia 1,662 位关注者
Enabling Tomorrow's Biomanufacturing by Measuring What Matters
关于我们
Andson Biotech is dedicated to advancing mass spectrometry workflows by enabling simple and fast sample-to-analysis workflows. Andson's DynaChip platform leverages advanced microfluidics packaged into an easy-to-use system to make sample prep for mass spec faster (and easier) for everyone. Our platforms are designed to be flexible - they couple with any commercial MS system for on-demand mass spec analysis with no expert training required. Our focus today is on improving sample preparation and workflow integration so that everyone can get more out of their mass spec.
- 网站
-
https://www.andsonbiotech.com
Andson Biotech的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Atlanta，Georgia
- 类型
- 私人持股
- 创立
- 2021
- 领域
- Advanced Therapies、Mass Spectrometry、Biotherapeutics、Biomanufacturing、Process Control、Process Analytical Technologies (PATs)、Cell and Gene Therapies和Biologics
地点
-
主要
获取路线
US，Georgia，Atlanta
Andson Biotech员工
动态
-
Thanks Phase Two Ventures for your support, glad to have investors like you on our side.
Congratulations to Mason A. Chilmonczyk, PhD and the Andson Biotech team for closing their seed round. Phase Two is excited to be part of their journey in making Mass Spec workflows for biologics much easier. The DynaCHIP technology seamlessly integrates into existing mass spec workflows, significantly reducing sample prep times. https://lnkd.in/earvvJfv